Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

February 28, 2007

Conditions
Pulmonary Hypertension
Interventions
DRUG

Sildenafil citrate

Trial Locations (65)

1070

Pfizer Investigational Site, Brussels

1529

Pfizer Investigational Site, Budapest

2010

Pfizer Investigational Site, Darlinghurst

2100

Pfizer Investigational Site, Copenhagen

2193

Pfizer Investigational Site, Parktown

Pfizer Investigational Site, Parktown West

3000

Pfizer Investigational Site, Leuven

3004

Pfizer Investigational Site, Melbourne

7505

Pfizer Investigational Site, Parow

8900

Pfizer Investigational Site, Zalaegerszeg

10032

Pfizer Investigational Site, New York

14050

Pfizer Investigational Site, Tlalpan Mexico

14080

Pfizer Investigational Site, Tlalpan

21287

Pfizer Investigational Site, Baltimore

27710

Pfizer Investigational Site, Durham

28041

Pfizer Investigational Site, Madrid

30625

Pfizer Investigational Site, Hanover

35233

Pfizer Investigational Site, Birmingham

35294

Pfizer Investigational Site, Birmingham

35392

Pfizer Investigational Site, Giessen

37232

Pfizer Investigational Site, Nashville

40138

Pfizer Investigational Site, Bologna

41345

Pfizer Investigational Site, Gothenburg

46200

Pfizer Investigational Site, Petaling Jaya

48109

Pfizer Investigational Site, Ann Arbor

49100

Pfizer Investigational Site, Petah Tikva

52621

Pfizer Investigational Site, Tel Litwinsky

53215

Pfizer Investigational Site, Milwaukee

55905

Pfizer Investigational Site, Rochester

56124

Pfizer Investigational Site, Pisa

56126

Pfizer Investigational Site, Pisa

59100

Pfizer Investigational Site, Kuala Lumpur

60637

Pfizer Investigational Site, Chicago

77030

Pfizer Investigational Site, Houston

80220

Pfizer Investigational Site, Denver

80262

Pfizer Investigational Site, Denver

90024

Pfizer Investigational Site, Los Angeles

90033

Pfizer Investigational Site, Los Angeles

90073

Pfizer Investigational Site, Los Angeles

90095

Pfizer Investigational Site, Los Angeles

90502

Pfizer Investigational Site, Torrance

92037

Pfizer Investigational Site, La Jolla

92093

Pfizer Investigational Site, La Jolla

92141

Pfizer Investigational Site, Clamart

168752

Pfizer Investigational Site, Singapore

35294-0006

Pfizer Investigational Site, Birmingham

92103-8320

Pfizer Investigational Site, San Diego

02111

Pfizer Investigational Site, Boston

37232-5735

Pfizer Investigational Site, Nashville

05403-900

Pfizer Investigational Site, São Paulo

140 00

Pfizer Investigational Site, Prague

140 21

Pfizer Investigational Site, Prague

04103

Pfizer Investigational Site, Leipzig

Unknown

Pfizer Investigational Site, Shatin NT

1081 HV

Pfizer Investigational Site, Amsterdam

01-138

Pfizer Investigational Site, Warsaw

41-800

Pfizer Investigational Site, Zabrze

443-721

Pfizer Investigational Site, Suwon

08035

Pfizer Investigational Site, Barcelona

08036

Pfizer Investigational Site, Barcelona

CB3 8RE

Pfizer Investigational Site, Papworth Everard

S10 2JF

Pfizer Investigational Site, Sheffield

NE7 7DN

Pfizer Investigational Site, Newcastle upon Tyne

CB4 9EL

Pfizer Investigational Site, Cambridge

G11 6NT

Pfizer Investigational Site, Glasgow

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00159887 - Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter